Holiday Notice: Expect delayed shipping. Orders ship 4/6.
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.

HMG (Human Menopausal Gonadotropin) — Published Research

Reviewed by: Dr. Sarah Chen, PharmD| Last updated: February 27, 2026|For laboratory reference only

← Back to HMG (Human Menopausal Gonadotropin) product page

Research Library

Published research on gonadotropins — for educational purposes only

FSH and LH Receptor Signaling Pathways

FSH binds to the FSH receptor (FSHR), primarily expressed on ovarian granulosa cells and testicular Sertoli cells. The FSHR is a glycoprotein hormone receptor that couples to Gαs, activating adenylyl cyclase and increasing cAMP levels. LH activity targets the LH/CG receptor (LHCGR) on theca cells and Leydig cells. Both receptors also signal through Gαq, Gαi, and β-arrestin pathways. The combined FSH/LH activity in HMG activates both receptor systems, enabling coordinated signaling research in reproductive cell models.

Simoni M et al. “The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology.” Endocr Rev. 1997. PubMed

HP-hMG Characterization and Clinical Research

Highly purified human menopausal gonadotropin (HP-hMG) preparations have been compared to recombinant FSH (rFSH) in clinical research settings. Studies have characterized the pharmacokinetics, pharmacodynamics, and biological activity profiles of different gonadotropin preparations. The presence of LH activity in HMG distinguishes it from FSH-only preparations and has been investigated for its effects on follicular steroidogenesis and oocyte development markers in research and clinical models.

Coomarasamy A et al. “Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis.” Hum Reprod. 2008. PubMed

LH Activity in Follicular Steroidogenesis

The two-cell, two-gonadotropin model describes the coordinated action of LH on theca cells and FSH on granulosa cells in follicular steroidogenesis. LH stimulates theca cell androgen production (androstenedione), which is then aromatized to estradiol by FSH-stimulated aromatase in granulosa cells. Research using HMG in cell culture and in vivo models investigates the effects of combined FSH/LH stimulation on estradiol production, follicular growth markers, and downstream steroidogenic enzyme expression.

Hillier SG. “Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis.” Hum Reprod. 1994. PubMed

Disclaimer: All research citations are provided for educational purposes only. These references describe findings from in vitro and animal model studies. This information does not constitute medical advice and should not be interpreted as endorsement of any specific application.

Reviewed by

Dr. Sarah Chen, PharmD

Research pharmacologist specializing in peptide therapeutics. Reviews published clinical data and pharmacological research for accuracy and completeness.

Editorial Review

Reviewed by Dr. Sarah Chen, PharmD and Dr. James Porter, PhD — Panda Peptides Research Team.

Last reviewed: April 2026.

This content summarizes published peer-reviewed research for educational purposes only. It is not medical advice and does not constitute a recommendation for any specific compound or protocol.